SABIC to Build Catalyst Plants in Saudi Arabia

SABIC has announced it is planning to build three new plants in Saudi Arabia to produce catalysts used in the manufacture of chemicals and polymers.

“SABIC's investment in catalysts will contribute to securing our needs and that of the petrochemical manufacturers in the region,” said acting CEO Abdulrahman Al-Fageeh. He added that despite Saudi leadership in the energy and petrochemical industries, the Kingdom relies to a large extent on catalyst imports, increasing operational risks in the event of any supply chain disruption.

The catalyst plants will form part of a first package of projects for Saudi Arabia’s Shareek program, launched in March 2021 to increase domestic investments of private sector companies through support from government-approved incentives.

SABIC added that it is collaborating with Shareek to “identify the most important enablers and drivers to build the catalyst industry in the Kingdom.”

Last year, Sabic purchased Clariant’s 50% share in the company’s former joint venture Scientific Design, taking full control. Scientific Design is a licensor of high-performance process technologies and a producer of catalysts. The deal allowed SABIC to secure a key catalyst that it uses in glycol manufacturing.

Author: Elaine Burridge, Freelance Journalist

© SABIC (Hadeed)
© SABIC (Hadeed)

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.